Mucolytic therapy of ARD in pregnant women

Acute respiratory disease (ARD) is one of the most common pathologies in pregnant women. During their pregnancy, about 2/3 of women suffer from one or several episodes of ARD of any severity. It is vital to study the issue because, in a certain percentage of cases, ARD pathogens may directly or indi...

Full description

Saved in:
Bibliographic Details
Published inMedicinskij sovet no. 8; pp. 38 - 43
Main Authors R. A. Bontsevich, O. V. Golovchenko
Format Journal Article
LanguageRussian
Published Remedium Group LLC 01.12.2013
Subjects
ambroxol
ard
arvi
bronchitis
cough
mucolytics
pregnancy
treatment
амброксол
беременность
бронхит
кашель
лечение
муколитики
орви
орз
Online AccessGet full text

Cover

More Information
Summary:Acute respiratory disease (ARD) is one of the most common pathologies in pregnant women. During their pregnancy, about 2/3 of women suffer from one or several episodes of ARD of any severity. It is vital to study the issue because, in a certain percentage of cases, ARD pathogens may directly or indirectly cause damage to the fetus or break the normal gestation course. Optimal therapy of ARD which is often manifested in cough syndrome has not been thoroughly studied till now. The paper talks about the specifics of acute respiratory diseases (except for pneumonia) in pregnant women. The authors share their experience of including Ambroxol in the complex therapy of cough syndrome.
ISSN:2079-701X
2658-5790
DOI:10.21518/2079-701X-2013-8-38-43